JPS53132533A - Aniline derivative having mental stabilizing effect process for preparing same intermediate useful for preparation thereof and medical composition containing same - Google Patents

Aniline derivative having mental stabilizing effect process for preparing same intermediate useful for preparation thereof and medical composition containing same

Info

Publication number
JPS53132533A
JPS53132533A JP4763078A JP4763078A JPS53132533A JP S53132533 A JPS53132533 A JP S53132533A JP 4763078 A JP4763078 A JP 4763078A JP 4763078 A JP4763078 A JP 4763078A JP S53132533 A JPS53132533 A JP S53132533A
Authority
JP
Japan
Prior art keywords
preparation
composition containing
effect process
stabilizing effect
medical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4763078A
Other languages
English (en)
Inventor
Suchiyuwaato Hatsudori Maikeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of JPS53132533A publication Critical patent/JPS53132533A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
JP4763078A 1977-04-22 1978-04-21 Aniline derivative having mental stabilizing effect process for preparing same intermediate useful for preparation thereof and medical composition containing same Pending JPS53132533A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16765/77A GB1561023A (en) 1977-04-22 1977-04-22 2-methoxy - 5 - chloro aniline derivatives

Publications (1)

Publication Number Publication Date
JPS53132533A true JPS53132533A (en) 1978-11-18

Family

ID=10083254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4763078A Pending JPS53132533A (en) 1977-04-22 1978-04-21 Aniline derivative having mental stabilizing effect process for preparing same intermediate useful for preparation thereof and medical composition containing same

Country Status (15)

Country Link
US (3) US4223034A (ja)
JP (1) JPS53132533A (ja)
AU (1) AU518729B2 (ja)
BE (1) BE866057A (ja)
CA (1) CA1136137A (ja)
DE (1) DE2816884A1 (ja)
DK (1) DK172578A (ja)
ES (4) ES469008A1 (ja)
FR (1) FR2387955A1 (ja)
GB (1) GB1561023A (ja)
IE (1) IE46802B1 (ja)
IL (1) IL54438A (ja)
NL (1) NL7804203A (ja)
SE (1) SE7804483L (ja)
ZA (1) ZA781831B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006519805A (ja) * 2003-03-08 2006-08-31 グラクソ　グループ　リミテッド バニロイド受容体拮抗活性を有する尿素誘導体
JP2007502258A (ja) * 2003-08-14 2007-02-08 グラクソ　グループ　リミテッド バニロイド受容体モジュレーターとして用いるためのピペリジン／シクロヘキサンカルボキサミド誘導体

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE431092B (sv) * 1979-07-10 1984-01-16 Thuresson Af Ekenstam Bo Terapeutiskt aktiva, substituerade piperidinkarboxianilider
IL61972A0 (en) * 1980-01-30 1981-02-27 Beecham Group Ltd Azabicyclic compounds,their preparation and pharmaceutical compositions containing them
NZ196324A (en) 1980-03-01 1983-09-02 Wyeth John & Brother Ltd Piperidine derivatives and pharmaceutical compositions piperidine and pyridinium intermediates
IN156879B (ja) * 1980-09-04 1985-11-30 Westinghouse Brake & Signal
EP0047620B1 (en) * 1980-09-10 1985-03-13 Beecham Group Plc Aryl diazabicyclyl amides, a process for their preparation and use
US4409225A (en) * 1981-03-16 1983-10-11 Beecham Group Limited Substituted benzamides
US4585774A (en) * 1981-05-08 1986-04-29 Otsuka Pharmaceutical Co., Ltd. Aniline derivatives and cardiotonic composition
GB8517854D0 (en) * 1985-07-15 1985-08-21 Roussell Lab Ltd Chemical compounds
EP0343307A1 (en) * 1988-05-26 1989-11-29 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. 4-Piperidinealkanamine derivatives
EP0968200A1 (en) * 1997-02-24 2000-01-05 ZymoGenetics, Inc. Calcitonin mimetics
FR2821356A1 (fr) 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
EP1603899B1 (en) 2003-03-06 2009-08-26 Glaxo Group Limited Heterocyclic urea derivatives for the treatment of pain
JP2006519806A (ja) 2003-03-07 2006-08-31 グラクソ　グループ　リミテッド 尿素誘導体および疼痛治療におけるバニロイド受容体拮抗剤としてのそれらの使用。

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1189553B (de) * 1962-08-09 1965-03-25 Degussa Verfahren zur Herstellung von racemischen und optisch aktiven Piperazinderivaten
DE1445672A1 (de) * 1962-08-09 1968-12-12 Degussa Verfahren zur Herstellung neuer 2-Aryl-alkyl-1-Basen
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
US3856857A (en) * 1970-02-13 1974-12-24 En Nom Collectif Science Union Amino acids and their derivatives
US3647877A (en) * 1970-04-13 1972-03-07 Mead Johnson & Co Aminopropionanilides
GB1459506A (en) * 1974-02-18 1976-12-22 Wyeth John & Brother Ltd Piperidine derivatives
GB1458898A (en) * 1974-03-18 1976-12-15 Science Union & Cie Ortho alkoxyanilides a process for their preparation and pharmaceutical compositions containing them
AR216043A1 (es) * 1974-03-21 1979-11-30 Anphar Sa Procedimiento para la preparacion de 1-derivados de benzoilamino-4-piperidina y sus sales fisiologicamente aceptables
JPS518283A (en) * 1974-07-09 1976-01-23 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5152176A (ja) * 1974-10-12 1976-05-08 Yoshitomi Pharmaceutical
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
GB1498884A (en) * 1975-04-15 1978-01-25 Wyeth John & Brother Ltd Aminoacetamide-pyridyl-tetrahydropyridyl and-piperidyl derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006519805A (ja) * 2003-03-08 2006-08-31 グラクソ　グループ　リミテッド バニロイド受容体拮抗活性を有する尿素誘導体
JP2007502258A (ja) * 2003-08-14 2007-02-08 グラクソ　グループ　リミテッド バニロイド受容体モジュレーターとして用いるためのピペリジン／シクロヘキサンカルボキサミド誘導体

Also Published As

Publication number Publication date
ES469008A1 (es) 1979-09-01
DE2816884A1 (de) 1978-11-02
NL7804203A (nl) 1978-10-24
IE780791L (en) 1978-10-22
ZA781831B (en) 1979-03-28
AU518729B2 (en) 1981-10-15
FR2387955B1 (ja) 1982-05-14
ES476863A1 (es) 1979-06-01
SE7804483L (sv) 1978-10-23
DK172578A (da) 1978-10-23
CA1136137A (en) 1982-11-23
IL54438A (en) 1981-10-30
BE866057A (fr) 1978-10-17
US4223034A (en) 1980-09-16
AU3516978A (en) 1979-10-25
ES476862A1 (es) 1979-06-01
GB1561023A (en) 1980-02-13
US4329344A (en) 1982-05-11
US4331816A (en) 1982-05-25
ES476864A1 (es) 1980-06-16
IE46802B1 (en) 1983-09-21
IL54438A0 (en) 1978-07-31
FR2387955A1 (fr) 1978-11-17

Similar Documents

Publication Publication Date Title
JPS52116492A (en) Alkyloxim derivative of novel 77aminothiazolylacetamide cephalospolanate process for preparing same and medical composition
JPS5392752A (en) Novel 11betaasubstituted 4*99dienesteroid derivative process for preparing same and pharmaceutical composition
PT67861A (en) Improvements in the process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing same
JPS5444644A (en) Triphenylalkene derivative*its manufacture and medical composition containing said derivative for antiestrogenic hormone effect
JPS52122632A (en) Medical composition and process for preparing same
GB2003471B (en) Heterocyclic compounds process for preparing them and medical compositions containing them
JPS53149936A (en) Novel aminoalkylbenzene derivative process for preparing same medical composition and application thereof
JPS53132533A (en) Aniline derivative having mental stabilizing effect process for preparing same intermediate useful for preparation thereof and medical composition containing same
JPS52151194A (en) Novel adenine derivatives process for preparing same and medical composition containing same
JPS5297921A (en) Aralkylaniline derivative* preparation thereof and medical composition containing same
JPS5390254A (en) Novel 11betaasubstituted 1*3*5*10**trienesteroid process for preparing same and pharmaceutical composition
JPS5283397A (en) 1*44benzoxazine and 1*44benzothiazine cyclic derivatives process for preparing same and medical composition having antiidepression activity containing same
JPS53103500A (en) Novel 20*211dinoreblmnamenine derivative process for preparing same and pharmaceutical composition
JPS53127497A (en) Novel pyroloquinoxaline process for preparing same and medical composition
JPS5473765A (en) Novel 66oxidatedd3*200dioxoopregnane derivatives*their manufacture and medical composition containing said compounds
JPS53121789A (en) Penicilline process for preparing and medical composition containing same
JPS5436225A (en) Novel 1*33diphenoxypropanee22one derivative process for preparing same and medicine containing same
JPS545926A (en) Novel nnacylmethyllchloroacetoanilide process for preparing same and herbicidal composition containing same as active component
JPS53149972A (en) Novel isoindoline derivative process for preparing same and medical composition containing same
JPS53119803A (en) Monofluorophosphateamine process for preparing same and composition containing same
JPS5277081A (en) Pfnicillins process for preparing same and medical composition containing same
JPS53141230A (en) Aminoalcohol derivative process for preparing same and medicine containing same
JPS53108996A (en) 33thiadiazolylthiomethyll77 aminothiazolylacetamide cephalospolanate process for preparing same and pharmaceutical composition
JPS5490167A (en) Novel tetracyclononane derivative*its manufacture and antivirulent medical composition containing it
JPS53119836A (en) Aniline derivatives process for preparing same and moldicide containing same as effective component